Skip to main content

Table 2 The laboratory data of plasma PCSK9 levels and lipid profile in rats

From: Impacts of ezetimibe on PCSK9 in rats: study on the expression in different organs and the potential mechanisms

Parameters

Group

 
 

Control (n = 15)

Ezetimibe (n = 15)

PCSK9 (ng/ml)

289.36 ± 109.51

661.37 ± 298.56*

TG (mmol/L)

0.75 ± 0.68

0.59 ± 0.46

TC (mmol/L)

2.15 ± 0.23

2.13 ± 0.37

LDL-C (mmol/L)

0.54 ± 0.15

0.52 ± 0.13

HDL-C (mmol/L)

1.12 ± 0.30

1.21 ± 0.26

  1. Data are expressed as mean ± SD. *p < 0.05, compared with control group.
  2. PCSK9: proprotein convertase subtilisin/kexin type 9; TG: triglycerides; TC: total cholesterol; LDL-C: low density lipoprotein cholesterol; HDL-C: high density lipoprotein cholesterol.
Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us